NEW YORK (GenomeWeb) – San Francisco-based Linkage Biosciences today announced the launch of a wholly-owned European subsidiary based in Geneva.

The move is in response to global demand for LinkSeq molecular tissue typing technology, the firm said in a statement. The real-time PCR-based human leukocyte antigen testing technology covers 12,000 alleles in a single test, the firm said.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.